|
Jul 28
|
Alector Presents Baseline Characteristics for INVOKE-2 Phase 2 Clinical Trial of AL002 at the Alzheimer's Association International Conference® 2024 (AAIC®)
|
|
Jul 23
|
Alector to Present Data on Pipeline Focus Areas at the Alzheimer's Association International Conference® (AAIC®) 2024
|
|
Jun 24
|
Prothena (PRTA) Moves 9.3% Higher: Will This Strength Last?
|
|
May 11
|
Here's Why We're Watching Alector's (NASDAQ:ALEC) Cash Burn Situation
|
|
May 9
|
Alector to Participate in Upcoming Healthcare Conferences
|
|
May 8
|
Alector (ALEC) Reports Q1 Loss, Tops Revenue Estimates
|
|
May 8
|
Alector Reports First Quarter 2024 Financial Results and Provides Business Update
|
|
Apr 25
|
Will Alector (ALEC) Report Negative Q1 Earnings? What You Should Know
|
|
Apr 11
|
The past five years for Alector (NASDAQ:ALEC) investors has not been profitable
|
|
Feb 1
|
With 67% institutional ownership, Alector, Inc. (NASDAQ:ALEC) is a favorite amongst the big guns
|
|
Jan 16
|
Alector Announces Proposed Public Offering of Common Stock
|
|
Dec 18
|
Alector, Inc. (NASDAQ:ALEC) Shares Fly 92% But Investors Aren't Buying For Growth
|
|
Dec 5
|
Wall Street Analysts Think Alector (ALEC) Could Surge 142.53%: Read This Before Placing a Bet
|
|
Nov 28
|
Alector to Host Two Virtual Research and Development Events Highlighting TREM2 and Progranulin Programs
|
|
Nov 8
|
We're Not Very Worried About Alector's (NASDAQ:ALEC) Cash Burn Rate
|
|
Nov 8
|
Alector to Participate in the Stifel Healthcare Conference
|
|
Nov 7
|
Alector Inc (ALEC) Reports Q3 2023 Financial Results with Key Clinical Advancements
|
|
Nov 7
|
Alector Reports Third Quarter 2023 Financial Results and Provides Business Update
|
|
Apr 27
|
Analysts Estimate Alector (ALEC) to Report a Decline in Earnings: What to Look Out for
|